This contract expires in 258 days (Dec 31, 2026).
FIRM FIXED PRICE
EXACT SCIENCES CORPORATION - ONCOTYPE DX BREAST CANCER TESTING
PIID: 36C26024F0122
Signed Date: Dec 10, 2025Effective Date: Jan 1, 2024End Date: Closes in 258 days
Key Details
Description
ONCOTYPE DX BREAST CANCER TESTING
Contractor Information
Similar Awards
MODIFICATION P1 TO ADD AN ADDITIONAL POC FOR FMI AND ADDITIONAL REPORT
FOUNDATION MEDICINE, INC.
$24.7M
LABORATORY PROFICIENCY TESTING
COLLEGE OF AMERICAN PATHOLOGISTS
$18.4M
TASK ORDER FOR REF LAB BRIDGE WHILE SOLIITATION IS CURRENTLY ACTIVE TO AVOID SERVICE DISRUPTION.
QUEST DIAGNOSTICS INCORPORATED
$9.3M
PRIMARY REFERENCE LABORATORY TESTING / COURIER SERVICES / PHLEBOTOMY
QUEST DIAGNOSTICS INCORPORATED
$8.4M
VISN 7 REFERENCE LAB SERVICES
QUEST DIAGNOSTICS INCORPORATED
$8.3M
Stay Updated
Get notified about new opportunities matching your interests.
Related
Agencies
NAICS Codes
Vendors